Shopping Cart
- Remove All
 
Your shopping cart is currently empty
OSMR Protein, Human, Recombinant (His) V2 is expressed in HEK293 Cells. The accession number is Q99650-1.

| Pack Size | Price | Availability | Quantity | 
|---|
| Biological Activity | Immobilized Human OSMR, His Tag at 1 μg/ml (100 μl/Well) on the plate. Dose response curve for Anti-OSMR Antibody, hFc Tag with the EC50 of 4.4 ng/ml determined by ELISA.  | 
| Description | OSMR Protein, Human, Recombinant (His) V2 is expressed in HEK293 Cells. The accession number is Q99650-1.  | 
| Species | Human  | 
| Expression System | HEK293 Cells  | 
| Tag | C-His | 
| Accession Number | Q99650-1 | 
| Synonyms | PLCA1,OSMRB,oncostatin M receptor,IL-31RB  | 
| Construction | Glu28-Met740  | 
| Protein Purity | > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC  | 
| Molecular Weight | 82.2 kDa (Predicted); 110-140 kDa (Due to glycosylation) | 
| Endotoxin | < 1.0 EU/μg of the protein as determined by the LAL method. | 
| Formulation | Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. | 
| Stability & Storage | Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.  | 
| Shipping | In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice. | 
| Research Background | OSMR is targeted to the mitochondrial matrix via the presequence translocase-associated motor complex components, mtHSP70 and TIM44. OSMR interacts with NADH ubiquinone oxidoreductase 1/2 (NDUFS1/2) of complex I and promotes mitochondrial respiration. Deletion of OSMR impairs spare respiratory capacity, increases reactive oxygen species, and sensitizes BTSCs to IR-induced cell death.  | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.